From NPR.

The FDA has approved another obesity pill, called Foundayo, from pharmaceutical maker Eli Lilly.

Although Eli Lilly is the same company behind Zepbound, the blockbuster injectable obesity medicine, the company decided not to take Zepbound’s main ingredient and make it in pill form. Instead, the company developed a new ingredient: orforglipron. The pill can be taken any time without food or water restrictions. It should be available in pharmacies in the coming weeks.

Lilly hasn’t announced a list price yet, but it says people with commercial insurance could pay as little as $25 a month, and for people paying cash, the lowest dose will cost $149 a month.

Check out NPR News Now wherever you listen to podcasts for more of today’s news.